Javascript must be enabled to continue!
Lymphocyte‐mediated cytotoxicity against tumor cells. II. Characteristics and tissue distribution of concanavalin A‐ activated cytotoxic effector cells
View through CrossRef
AbstractIn vivo or in vitro activation of cytotoxic effector lymphocytes by concanavalin A (Con A) has been shown to result in a population of effector cells exhibiting a degree of immunological specificity when Con A was present during the cytotoxic assay (Waterfield, J.D. et al., Cell. Immunol. 1975. 17: 392). In this communication we have characterized the Con A‐activated effector cell by physical criteria and tried to assign it to a given subpopulation of thymus‐derived lymphocytes. It was shown that macrophages played no role in target cell lysis in this system, nor was their presence required for Con A activation of the effector cell. The effector cell proved insensitive to anti‐Θ serum, but was classified as a T cell by the enrichment of cytotoxicity when a purified population of T cells was activated by Con A in vitro and by the failure to activate the effector cell in nude mice. Precursors of the effector cell were shown to reside primarily in the spleen, to be radioresistant up to 400 R, and to be short‐lived after adult thymectomy. Thus, the effector cell can be classified with the TI population of T cells and has similar characteristics as a cytolytically active cell described by Stobo et al. (J. Immunol. 1973. 110: 362, 652).
Title: Lymphocyte‐mediated cytotoxicity against tumor cells. II. Characteristics and tissue distribution of concanavalin A‐ activated cytotoxic effector cells
Description:
AbstractIn vivo or in vitro activation of cytotoxic effector lymphocytes by concanavalin A (Con A) has been shown to result in a population of effector cells exhibiting a degree of immunological specificity when Con A was present during the cytotoxic assay (Waterfield, J.
D.
et al.
, Cell.
Immunol.
1975.
17: 392).
In this communication we have characterized the Con A‐activated effector cell by physical criteria and tried to assign it to a given subpopulation of thymus‐derived lymphocytes.
It was shown that macrophages played no role in target cell lysis in this system, nor was their presence required for Con A activation of the effector cell.
The effector cell proved insensitive to anti‐Θ serum, but was classified as a T cell by the enrichment of cytotoxicity when a purified population of T cells was activated by Con A in vitro and by the failure to activate the effector cell in nude mice.
Precursors of the effector cell were shown to reside primarily in the spleen, to be radioresistant up to 400 R, and to be short‐lived after adult thymectomy.
Thus, the effector cell can be classified with the TI population of T cells and has similar characteristics as a cytolytically active cell described by Stobo et al.
(J.
Immunol.
1973.
110: 362, 652).
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Association of T lymphocytes level and clinical severity in patients of COVID-19 in Shenzhen China
Association of T lymphocytes level and clinical severity in patients of COVID-19 in Shenzhen China
To explore the correlation between T lymphocytes and clinical severity in patients of COVID-19. A total of 183 COVID-19 patients were recruited in Shenzhen Third People’s Hospital ...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Abstract
Introduction
Sacrococcygeal teratoma (SCT) is a rare embryonal tumor that occurs in the sacrococcygeal region, with an incidence of about 1 in 35,000 to 40,000 live births...
Nature Products Enhance NKG2D Ligands Expression of CD123+CD34+CD38− Leukemia Stem Cells for Stimulating Cytotoxicity of NKG2D+ Cells to Themselves
Nature Products Enhance NKG2D Ligands Expression of CD123+CD34+CD38− Leukemia Stem Cells for Stimulating Cytotoxicity of NKG2D+ Cells to Themselves
Abstract
CD123+CD34+CD38− leukemia cells regarded as leukemia stem cells, not only refractory to chemotherapeutics but also resistant to immune response such as cyto...
Supplementary Data from Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors
Supplementary Data from Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors
<p>Supplementary Methods, Supplementary Figures S1-S15 Fig. S1. Purification and binding specificity of MV-encoded BiTEs. (A) Purification of MV-expressed BiTEs. Vero cells w...
First-in-class immunomodulatory anti-heat shock protein 70 (HSP70) antibody demonstrates broad antitumor activity across myeloma, lymphoma, and solid tumor models
First-in-class immunomodulatory anti-heat shock protein 70 (HSP70) antibody demonstrates broad antitumor activity across myeloma, lymphoma, and solid tumor models
Abstract
Background: Treatment resistance and relapse in myeloma and lymphoma are driven by diverse immunosuppressive me...

